In addition, log-rank test revealed that the five-year survival rate of AQP9 low-expression group was notably poorer compared with the high-expression counterpart, suggesting that AQP9 could be closely associated with the progression of HCC. The gene discussed is AQP9; the disease is hepatocellular carcinoma.